[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60310928D1 - Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird - Google Patents

Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird

Info

Publication number
DE60310928D1
DE60310928D1 DE60310928T DE60310928T DE60310928D1 DE 60310928 D1 DE60310928 D1 DE 60310928D1 DE 60310928 T DE60310928 T DE 60310928T DE 60310928 T DE60310928 T DE 60310928T DE 60310928 D1 DE60310928 D1 DE 60310928D1
Authority
DE
Germany
Prior art keywords
peptide derivative
intra
oral cavity
pharmaceutical composition
ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310928T
Other languages
English (en)
Other versions
DE60310928T2 (de
Inventor
Robert Ramage
Robin Plevin
Thomas Shaw
Lu Jiang
Claire Young
Lang Harvey
Pu Wang
Toru Kanke
Junichi Kawagoe
Mototsugu Kabeya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
University of Strathclyde
Kowa Co Ltd
Original Assignee
University of Edinburgh
University of Strathclyde
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh, University of Strathclyde, Kowa Co Ltd filed Critical University of Edinburgh
Application granted granted Critical
Publication of DE60310928D1 publication Critical patent/DE60310928D1/de
Publication of DE60310928T2 publication Critical patent/DE60310928T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60310928T 2002-06-10 2003-06-10 Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird Expired - Lifetime DE60310928T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0213286.8A GB0213286D0 (en) 2002-06-10 2002-06-10 Par-2-Activating peptide derivative and pharmaceutical composition using the same
GB0213286 2002-06-10
PCT/JP2003/007333 WO2003104268A1 (en) 2002-06-10 2003-06-10 Par-2-activating peptide derivative and pharmaceutical composition using the same

Publications (2)

Publication Number Publication Date
DE60310928D1 true DE60310928D1 (de) 2007-02-15
DE60310928T2 DE60310928T2 (de) 2007-10-11

Family

ID=9938287

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310928T Expired - Lifetime DE60310928T2 (de) 2002-06-10 2003-06-10 Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird

Country Status (12)

Country Link
US (1) US7541339B2 (de)
EP (1) EP1511765B1 (de)
JP (1) JP4263169B2 (de)
KR (1) KR20050011742A (de)
CN (1) CN1659183A (de)
AT (1) ATE350397T1 (de)
AU (1) AU2003238697A1 (de)
CA (1) CA2488937A1 (de)
DE (1) DE60310928T2 (de)
GB (1) GB0213286D0 (de)
TW (1) TW200400971A (de)
WO (1) WO2003104268A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4653516B2 (ja) * 2004-02-27 2011-03-16 扶桑薬品工業株式会社 涙液分泌促進ペプチドおよびその組成物
US20090012263A1 (en) 2004-09-30 2009-01-08 Kowa Company, Ltd. Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates
JP4927566B2 (ja) * 2004-12-28 2012-05-09 興和株式会社 Ｐａｒ−２アゴニスト
US8133864B2 (en) 2005-03-29 2012-03-13 Kowa Company, Ltd. PAR-2 agonist
WO2010128016A2 (en) * 2009-05-04 2010-11-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Par2 agonists for use in the treatment or prevention of influenza virus type a infections
EP2335717A1 (de) 2009-11-16 2011-06-22 Institut National De La Recherche Agronomique PAR-1-Antagonisten zur Verwendung bei der Behandlung oder Prävention von Influenzavirus-Typ-A-Infektionen
WO2013159181A1 (en) 2012-04-28 2013-10-31 Litens Automotive Partnership Adjustable tensioner
WO2014173859A2 (en) 2013-04-22 2014-10-30 Institut National De La Recherche Agronomique Par-4 antagonists for use in the treatment or prevention of influenza virus type a infections
HK1223096A1 (zh) 2013-09-25 2017-07-21 Vertex Pharmaceuticals Incorporated 用作par-2信號通路抑制劑的咪唑並噠嗪
KR20210003716A (ko) 2018-04-26 2021-01-12 라이온 가부시키가이샤 외분비 촉진제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037324A (en) 1996-01-04 2000-03-14 Leukosite, Inc. Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
GB9908513D0 (en) 1999-04-15 1999-06-09 Rolls Royce Plc Molecular cloning of a new DNA sequence for protease activated receptor 2
US6908900B2 (en) 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
JP3677421B2 (ja) 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
JP4065642B2 (ja) 2000-02-24 2008-03-26 扶桑薬品工業株式会社 消化器系疾患の予防、治療用組成物
US7214655B2 (en) * 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin

Also Published As

Publication number Publication date
ATE350397T1 (de) 2007-01-15
GB0213286D0 (en) 2002-07-24
JP2005538961A (ja) 2005-12-22
JP4263169B2 (ja) 2009-05-13
EP1511765B1 (de) 2007-01-03
DE60310928T2 (de) 2007-10-11
US20050222384A1 (en) 2005-10-06
KR20050011742A (ko) 2005-01-29
CA2488937A1 (en) 2003-12-18
EP1511765A1 (de) 2005-03-09
WO2003104268A1 (en) 2003-12-18
US7541339B2 (en) 2009-06-02
EP1511765A4 (de) 2005-10-12
AU2003238697A1 (en) 2003-12-22
CN1659183A (zh) 2005-08-24
AU2003238697A8 (en) 2003-12-22
TW200400971A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
RU2005123807A (ru) Тетрагидро-4н-пиридо[1,2-а]пиримидины и родственные соединения, полезные в качестве ингибиторов вич-интегразы
NO20034523D0 (no) Pyrazolderivater for behandling av HIV
WO2000046198A8 (en) Anti-inflammatory indole derivatives
EA200500304A1 (ru) Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
PT1086124E (pt) Ciclosporinas novas
AR036906A1 (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4
EA200301094A1 (ru) Аминопроизводные как ингибиторы протеазы
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
NO20056010L (no) Biaryloksymetylaren-karboksylsyrer
DE60310928D1 (de) Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
CY1111188T1 (el) Αντιβακτηριακα παραγωγα κινολινης
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
EE9800144A (et) Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
AR007352A1 (es) Derivados sustituidos de bencimidazol, proceso para su preparacion, formulacion farmaceutica que los contiene, y uso de dichos derivados para la manufactura de medicamentos
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
RU2010116779A (ru) Производное амида индазолакриловой кислоты
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
CY1105939T1 (el) Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
BR0314860A (pt) Derivados de pirazol
BR0315620A (pt) Derivados de n-benzodioxolil, n-benzodioxanil e n-benzodioxepinil arilcarboxamida, e composições farmacêuticas compreendendo os mesmos
PE20040658A1 (es) Derivados de 3-guanidinocarbonil-1-heteroaril-pirrol, procedimiento de preparacion e intermediarios de este procedimiento y composiciones farmaceuticas que los comprenden
WO2024100452A3 (en) Heterocyclic compounds as sting agonists

Legal Events

Date Code Title Description
8364 No opposition during term of opposition